Suchergebnisse - "Albrecht, Jana D"

PubPharm (7)

1

Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma : a multicenter phase 2 study

enthalten in: Blood | 2023

von Nicolay, J. | Melchers, S. | Albrecht, J. | +13

CommentIn: Blood. 2023 Aug 31;142(9):753-754. - PMID 37651156

2

Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma

enthalten in: EMBO molecular medicine | 2022

von Sorger, H. | Dey, S. | Vieyra-Garcia, P. | +43

3

Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects

enthalten in: Acta dermato-venereologica | 2022

von Albrecht, J. | Ninosu, N. | Barry, D. | +4

4

Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma

enthalten in: EMBO Molecular Medicine | 2022

von Sorger, H. | Dey, S. | Vieyra‐Garcia, P. | +43

5

Dimethyl fumarate (DMF) therapy in CTCL : results from a clinical phase II study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Nicolay, J. | Albrecht, J. | Assaf, C. | +7

6

CCR4 in cutaneous T-cell lymphoma : Therapeutic targeting of a pathogenic driver

enthalten in: European journal of immunology | 2021

von Nicolay, J. | Albrecht, J. | Alberti-Violetti, S. | +1

7

CCR4 in cutaneous T‐cell lymphoma : Therapeutic targeting of a pathogenic driver

enthalten in: European Journal of Immunology | 2021

von Nicolay, J. | Albrecht, J. | Alberti‐Violetti, S. | +1

1
[1]